The relationship between demographic and health factors, social support factors and antiretroviral adherence in HIV/AIDS patients, Um-Najaroen Province, Thailand

Main Article Content

Nongnit Teerawatanasuk
Anun Chaikoolvatana
Somjet Pealkum

Abstract

Introduction: This study evaluated the health factors, social support factors and antiretroviral medicationadherence in HIV/AIDS patients, Um-Najaroen Province, Thailand. Materials and Methods: In this cross-sectionalquestionnaire survey study, 198 HIV/AIDS patients were recruited via simple random sampling. The questionnairesurvey was analysed using descriptive analysis, one-way Analysis of Variance, Pearson’s product momentcorrelation coeffi cient, discriminant analysis, and t–test. Results: The results showed that most subjects were male(54%) with average age of 36.4 years, and were HIV positive and undergone anti-retroviral agent (ARV) therapyfor approximately 3-5 years. The ARV formula was d4T + 3TC + NVP with average CD4 level of 66 cells/ml at thebeginning of therapy and 387cells/ml at the time of study. Most volunteers complied with their ARV medications.Interestingly, regarding demographic and health factors, only marital status and self revealability were statisticallyrelated to ARV adherence. For social support factors, overall most volunteers had a moderate level in the individualfactors, especially for basic knowledge, essential information, and social affi rmation which were statistically relatedto antiretroviral adherence (p< 0.05). Conclusion: Demographic and health factors, were statistically related toARV adherence. Similarly, all social support factors including emotional as well as information support, instrumentalaids, and affi rmation were positively statistically related to antiretroviral adherence (p< 0.05).

Article Details

Section
Pharmaceutical Practice
Author Biographies

Nongnit Teerawatanasuk, Department of Pharmaceutical Science, Ubon Ratchathani University, Thailand 34190

Department of Pharmaceutical Science, Ubon Ratchathani University, Thailand 34190

Anun Chaikoolvatana, Department of Pharmaceutical Science, Ubon Ratchathani University, Thailand 34190

Department of Pharmaceutical Science, Ubon Ratchathani University, Thailand 34190

Somjet Pealkum, Provincial Administration Organization, Um-Najaroen, Thailand 37000

Provincial Administration Organization, Um-Najaroen, Thailand 37000

References

Ammassari A, Murri R, Pezzotti P, et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defi c Syndr 2001; 25: 445-9.

Barrera M Jr, Ainley SL. The structure of social support: A conceptual and empirical analysis. J Community Psychol 1983; 11: 133-43.

Bureau of Epidemiology, Thailand. An annual report of risk behavior of HIV/AID surveillance, Thailand. Nonthaburi: Ministry of Public Health, 2001.

Bureau of Epidemiology, Thailand. An annual report of risk behavior of HIV/AID surveillance, Thailand from September 1984 to 31th January 2002. Nonthaburi: Ministry of Public Health; 2002.

Darder M, Michaels D, Boulle A, et al. Determinants of short and long-term adherence to antiretroviral treatment in resource-poor settings. The 15thInternational AIDS Conference; 11th -16th July 2004; Bangkok. Int Conf AIDS 2004; 11-16; 15

Department of AIDS/Sexual Transmitted Disease Control. A monthly report of the national access of ARV medications in Febrauary 2007. Am-nartcharoen: Division of Public Health, Am-nartcharoen, 2007a.

Department of AIDS/Sexual Transmitted Disease Control. A monthly report of the national access of ARV medications in January 2007. Am-nartcharoen: Division of Public Health, Am-nartcharoen, 2007b.

Department of Health and Human Services (DHHS) (2004). A textbook of guidelines for use of antiretroviral agents in HIV-1-infacted adults and adolescents. [cited 2004 Mar 23]; Available from: URL: http://AIDSinfo.nih.gov/

Gifford AL, Bormann JE, Shively MJ, et al. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiret-roviral regimens. J Acquir Immune Defi c Syndr 2000; 23: 386-95.

Golin CE, Liu H, Hays RD, et al. A prospective study of Predictors of adherence to combination antiretroviral medication. J Gen Intern Med 2002; 17: 812-3.

House JS. Measure and concept of social support. In: Cohen S, Shyme SL, editors. Social support and health. Orlando: Academic Press; 1985: 83-108.

Kahn RL. Aging social support. In Riley MW, editor. Aging from birth to death: Interdisciplinary Perspectives. Boulder. CO: Westview Press 1979: 77-91.

Inthisak K. Adhrerence to antiretroviral therapy in HIV-infected adults. IJPS 2008; 4: 34-41.

Kaplan BH, Cassel JC, Gore S. Social support and health. Med Care 1977; 15: 47-58.

Kitajima T, Kobayashi Y, Chaipah W, et al. Access to antiretroviral therapy among HIV/AIDS patients in Khon Kaen province, Thailand. AIDS Care 2005; 17: 359 – 66.

Krejcie RV, Morgan, DW. Determining sample size for research activities. Educational and Psycho-logical Measurement 1970; 30: 607-10.

Langlee JK. Social Networks, Health Beliefs, and Preventive Health Behavior. J Health Soc Behav 1977; 18: 244-60.

Lieberman MA. The effect of social support on responses to stress. In: Golberger L, Brezmitz S, editors. Handbook of Stress: Theoretical and clinical aspects. New York: Free Press, MacMilland Publishing Company; 1972: 68-87

Little SJ, Holte S, Routy JP. Antiretroviral-drug resist-ance among patients recently infected with HIV. N Engl J Med 2002; 347: 385-94.

Maher K, Klimas N, Fletcher MA. Disease progression, adherence, and response to protease inhibitor therapy for HIV infection in an urban Veterans Affairs Medical Center. J Acquir Immune Defi c Syndr 1999; 22: 358-63.

Mannheimer S, Friedland G, Matts J, et al. The Con-sistency of adherence to antiretroviral therapy predicts biologic outcomes for Human Immunodefi ciency Virus-infected persons in clinical trials. Clin Infect Dis 2002; 34: 1115-21.

Mathews WC, Mar-Tang M, Ballard C, et al. Prevalence, predictors, and outcomes of early adherence after staring or changing antiretroviral therapy. AIDS Patient Care STDs 2002; 16: 157-72.

Ministry of Public Health, Thailand. A practical guideline: the development of the service and follow-up system of HIV/AIDS receiving ARV medications 2003. Bangkok: Express transportation organization of Thailand, 2003.

Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV Infection. Ann Int Med 2002; 133: 21-30.

Pender NJ. Health promotion in nursing practice. 2nded. California: Appleton and Lange; 1987.

Pender NJ. Health promotion in nursing practice. 3rded. Baltimore: Appleton and Lange. 1996.

Roberts KJ. Barriers to and facilitators of HIV-positive patients’ adherence to antiretroviral treatment regimens. AIDS Patient Care STDs 2000; 14: 155-68.

Thoits P, Peggy A. Conceptual, methodological, and theoretical problem in studying social support as a buffer against life stress. J Health Sol Behav 1982; 23: 145-59.

Tipanya T. The relationship between knowledge, perception regarding antiretroviral agents and adherence in Chiangmai province. [Thesis for The degree of Master of Public Health] Chiangmai: Graduate school Chiangmai University, 2004.

Vanhove GF, Schapiro JM, Winters MA. Patient compliance and drug failure in protease inhibitor monotherapy. JAMA 1996; 276: 1955-6.

Wagner GJ, Remien RH, Carballo-Dieguez A, et al. Correlates of adherence to combination antiretroviral therapy among member of HIV-positive mixed status couples. AIDS Care 2002; 14: 105-9.

Wanthana Maneesriwongul. The analysis of knowledge of ARV medication adherence regarding the promotion of ARV medication adherence in HIV/AIDS patients. Nonthaburi: The Agricultural Cooperative Federation of Thailand., Limited; 2004.